Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The novel bacteriocin romsacin from Staphylococcus haemolyticus inhibits Gram-positive WHO priority pathogens

31 Oct 2023

Abstract excerpt

ABSTRACT Staphylococcus haemolyticus is an increasingly relevant nosocomial pathogen. The combination of multi-drug resistance and ability to form biofilms makes S. haemolyticus infections difficult to treat. Bacteriocins are ribosomally synthesized antimicrobial peptides produced by bacteria to inhibit growth of often closely related bacteria. Due to differences in the modes of action between bacteriocins and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antimicrobial Resistance in Staphylococcus
Share to Microbial Metabolism and Applications
Share to Probiotics and Fermented Foods

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37905822
DOI: 10.1128/spectrum.00869-23

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The novel bacteriocin romsacin from Staphylococcus haemolyticus inhibits Gram-positive WHO priority pathogensPMID 37905822Read ↗

A bacteriocin-based treatment option for Staphylococcus haemolyticus biofilms.Semantic proximity Read ↗

Genomic Analysis of Bacteriocin-Producing Staphylococci: High Prevalence of Lanthipeptides and the Micrococcin P1 Biosynthetic Gene ClustersSemantic proximity Read ↗

Garvicin-SHAMU-LG6, A Novel Bacteriocin from Lactococcus garvieae That Exert Broad Antimicrobial Activity Against Drug-Resistant PathogensSemantic proximity Read ↗

Selective Bacteriocins: A Promising Treatment for Staphylococcus aureus Skin Infections Reveals Insights into Resistant Mutants, Vancomycin Resistance, and Cell Wall AlterationsSemantic proximity Read ↗

Broad-range lytic bacteriophages that kill Staphylococcus aureus local field strainsSemantic proximity Read ↗

Identification and structural characterization of novel bacteriocins by genome-wide screening of hypothetical mini-proteins in Staphylococcus aureusSemantic proximity Read ↗

Interactions between commensal Enterococcus faecium and Enterococcus lactis and clinical isolates of Enterococcus faeciumSemantic proximity Read ↗

Novel Group of Leaderless Multipeptide Bacteriocins from Gram-Positive BacteriaSemantic proximity Read ↗

Screening canine sources for novel antimicrobials reveals the circular broad-spectrum bacteriocin, caledonicin, produced by Staphylococcus caledonicusSemantic proximity Read ↗

Coagulase-Negative Staphylococci phages panorama: Genomic diversity and in vitro studies for a therapeutic use.Semantic proximity Read ↗

A Review on Enterocin DD14, the Leaderless Two-Peptide Bacteriocin with Multiple Biological Functions and Unusual Transport PathwaySemantic proximity Read ↗

Systematically investigating and identifying bacteriocins in the human gut microbiomeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.